Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 133 B, Issue 1, 2005, Pages 88-92

  Håkansson, Anna ^a   Westberg, Lars ^a   Nilsson, Staffan ^b   Buervenich, Silvia ^c   Carmine, Andrea ^c   Holmberg, Björn ^a   Sydow, Olof ^c   Olson, Lars ^c   Johnels, Bo ^a   Eriksson, Elias ^a   Nissbrandt, Hans ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Association; Cytokine; Inflammation; Microglia

Indexed keywords

ESTROGEN RECEPTOR BETA; INTERLEUKIN 6;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE INTERACTION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; ALLELES; ESTROGEN RECEPTOR BETA; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LINKAGE DISEQUILIBRIUM; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 19944431987     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30136     Document Type: Article

References (43)

1. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. 1995. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202(1-2):17-20.
2. Bolin LM, Strycharska-Orczyk I, Murray R, Langsten JW, Di Monte D. 2002. Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem 83(1):167-175.
3. Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, et al. 2001. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 31(8):2357-2361.
4. Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT, Ray A, Sehgal PB, Kidd KK, Cavalli-Sforza LL. 1988. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3(1): 8-16.
5. Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Pöti G, et al. 2001. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 88(10):1125-1128.
6. Czlonkowska A, Kurkowska-Jastrzebska I, Czlonkowski A, Peter D, Stefano GB. 2002. Immune processes in the pathogenesis of Parkinson's disease - A potential role for microglia and nitric oxide. Med Sci Monit 8(8):RA165-RA177.
7. Daniel SE, Lees AJ. 1993. Parkinson's Disease Society Brain Bank, London: Overview and research. J Neural Transm Suppl 39:165-172.
8. Dekker MC, Bonifati V, van Duijn CM. 2003. Parkinson's disease: Piecing together a genetic jigsaw. Brain 126(Pt 8):1722-1733.
9. Ershler WB, Keller ET. 2000. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-270.
10. Faltraco F, Burger K, Zill P, Teipel SJ, Moller HJ, Hampel H, Bondy B, Ackenheil M. 2003. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 51(4):578-579.
11. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369-1376.
12. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC. 1992. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89(3):883-891.
13. Greisenegger S, Endler G, Haering D, Schillinger M, Lang W, Lalouschek W, Mannhalter C. 2003. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 110(4):181-186.
14. Gruol DL, Nelson TE. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15(3):307-339.
15. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. 1997. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 94(4):1500-1505.
16. Hirano T. 1998. Interleukin 6 and its receptor: Ten years later. Int Rev Immunol 16(3-4):249-284.
17. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. 2001. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40(6):656-661.
18. Kristiansen OP, Nolsoe RL, Larsen L, Gjesing AM, Johannesen J, Larsen ZM, Lykkesfeldt AE, Karlsen AE, Pociot F, Mandrup-Poulsen T. 2003. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet 12(10):1101-1110.
19. Kuppers E, Ivanova T, Karolczak M, Beyer C. 2000. Estrogen: A multifunctional messenger to nigrostriatal dopaminergic neurons. J Neurocytol 29(5-6):375-385.
20. Ladenheim B, Krasnova IN, Deng X, Oyler JM, Polettini A, Moran TH, Huestis MA, Cadet JL. 2000. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol Pharmacol 58(6):1247-1256.
21. Leranth C, Roth RH, Elsworth JD, Naftolin F, Horvath TL, Redmond DE Jr. 2000. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory. J Neurosci 20(23):8604-8609.
22. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, et al. 2002. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4):985-993.
23. Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, et al. 2003. Familial aggregation of early-and late-onset Parkinson's disease. Ann Neurol 54(4):507-513.
24. Markopoulou K, Langston JW. 1999. Candidate genes and Parkinson's disease: Where to next? Neurology 53(7):1382-1383.
25. McGeer EG, McGeer PL. 2003. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27(5):741-749.
26. McGeer PL, Itagaki S, Boyes BE, McGeer EG. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38(8):1285-1291.
27. McGeer PL, Yasojima K, McGeer EG. 2001. Inflammation in Parkinson's disease. Adv Neurol 86:83-89.
28. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, et al. 2003. Immunolocalization of estrogen receptor beta in the mouse brain: Comparison with estrogen receptor alpha. Endocrinology 144(5):2055-2067.
29. Mizuta I, Nishimura M, Mizuta E, Yamasaki S, Ohta M, Kuno S, Ota M. 2001. Relation between the high production related allele of the interferon-gamma (IFN-gamma) gene and age at onset of idiopathic Parkinson's disease in Japan. J Neurol Neurosurg Psychiatry 71(6): 818-819.
30. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T. 1994. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147-150.
31. Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. 1996. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 211(1):13-16.
32. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R. 2002. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population [corrected]. Neuroreport 13(13):1645-1647.
33. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 1994. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93(3):944-950.
34. Ray P, Ghosh SK, Zhang DH, Ray A. 1997. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 409(1):79-85.
35. Rea IM, Ross OA, Armstrong M, McNerlan S, Alexander DH, Curran MD, Middleton D. 2003. Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev 124(4):555-561.
36. Ross OA, O'Neill C, Rea IM, Lynch T, Gosal D, Wallace A, Curran MD, Middleton D, Gibson JM. 2004. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. Hum Immunol 65(4):340-346.
37. Shughrue PJ, Lane MV, Merchenthaler I. 1997. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388(4):507-525.
38. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. 1999. Parkinson disease in twins: An etiologic study. Jama 281(4):341-346.
39. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F, Brusadelli A, Viviani B, Ciana P, Maggi A. 2001. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 21(6):1809-1818.
40. Wang L, Andersson S, Warner M, Gustafsson JA. 2001a. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 98(5):2792-2796.
41. Wang XY, Hurme M, Jylha M, Hervonen A. 2001b. Lack of association between human longevity and polymorphisms of IL-1 cluster, IL-6, IL-10 and TNF-alpha genes in Finnish nonagenarians. Mech Ageing Dev 123(1):29-38.
42. Westberg L, Håkansson A, Melke J, Niazi Shahabi H, Nilsson S, Buervenich S, Carmine A, Ahlberg J, Grundell M, Schulhof B, et al. 2004. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 29(8): 993-998.
43. Zareparsi S, Camicioli R, Sexton G, Bird T, Swanson P, Kaye J, Nutt J, Payami H, 2002. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 107(2):156-161.